2B Scientific adds business manager to support growth
2B Scientific has appointed Nihad Robinson as business manager.
Robinson joins the Upper Heyford, Oxfordshire firm from Cambridge Biosciences where she was responsible for technical sales in the South UK region. She has a degree in microbiology and a PhD in molecular biology, as well as being fluent in Arabic and French.
"I am very proud to be joining 2BScientific and look forward to helping develop the business," she said.
2B Scientific has also expanded its worldwide supplier network by signing deals with Spring Bioscience and BioDynamics.
"We are excited about our new partnerships with US-based Spring Bioscience and Japan's BioDynamics (Funakoshi)," said James Bernard, md of 2B Scientific. "Both of these companies have established businesses and the expertise that will help position the products successfully in the market."
2B Scientific has extended its catalogue portfolio to include Spring Bioscience's cancer markers and tumour suppressors, plus BioDynamic's Hetero-Stagger PCR Cloning Kit, which enables efficient and fast cloning of PCR products without needing any enzymatic procedures.
The firm also offers products from Acris Antibodies (Germany); Cosmo Bio (Japan); Symansis (New Zealand); and ExBio (Czech Republic), among others.
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model
Manufacturing
BioNTech to cut up to 1860 jobs and end COVID vaccine production in Germany
The German biotech has announced it will cease production at its manufacturing sites in Germany and Singapore in its Q1 earnings report, cutting up to 22% of its workforce in the process as it pivots from COVID-19 vaccines to oncology